Dr. Oh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3801 Miranda Ave
Palo Alto, CA 94304- Is this information wrong?
Education & Training
- Medical College of WisconsinMS, Clinical and Translational Science, 2010 - 2014
- University of Pennsylvania Health SystemFellowship, Gastroenterology, 2006 - 2007
- Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 2003 - 2006
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2001 - 2003
- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2000 - 2001
- University of Texas Southwestern Medical SchoolClass of 2000
- University of MichiganBSE, Chemical Engineering, 1992 - 1996
Certifications & Licensure
- WI State Medical License 2009 - 2025
- CA State Medical License 2015 - 2024
- WA State Medical License 2007 - 2009
- PA State Medical License 2006 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 43 citationsEtrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.David T. Rubin, Iris Dotan, Aaron DuVall, Yoram Bouhnik, Graham L. Radford-Smith, Peter D R Higgins, Daniel S Mishkin, Pablo Arrisi, Astrid Scalori, Young S Oh, Swati ...> ;The Lancet. Gastroenterology & Hepatology. 2021 Nov 16
- 31 citationsEtrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3...Severine Vermeire, Peter L. Lakatos, Timothy Ritter, Stephen B. Hanauer, Brian Bressler, Reena Khanna, Kim L. Isaacs, Saumin Shah, AK Kadva, Helen Tyrrell, Young S Oh,...> ;The Lancet. Gastroenterology & Hepatology. 2021 Nov 16
- 44 citationsEtrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.Silvio Danese, Jean-Frederic Colombel, Milan Lukas, Javier P Gisbert, Geert R. D'Haens, Bu'Hussain Hayee, Remo Panaccione, Hyun-Chul Kim, Walter Reinisch, Helen Tyrrel...> ;The Lancet. Gastroenterology & Hepatology. 2021 Nov 16
- Join now to see all
Committees
- Member, Membership and Diversity Committee, American Society for Gastrointestinal Endoscopy 2015 - Present
- Member, Publications Committee, American College of Gastroenterology 2013 - Present
- Member, Editorial Board, Gastrointestinal Endoscopy 2011 - 2015
Professional Memberships
- Member
- Fellow
- Member
Hospital Affiliations
- VA Palo Alto Heath CarePalo Alto, California
Industry Relationships
- Consultant, Boston Scientific Corporation2011 - 2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: